1 |
Amado, N., Predes, D., Moreno, M., Carvalho, I., Mendes, F. and Abreu, J. 2014. Flavonoids and Wnt/-catenin signaling: potential role in colorectal cancer therapies. Int. J. Mol. Sci. 15, 12094-12106.
DOI
|
2 |
Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M. and Abreu, J. G. 2011. Flavonoids: potential Wnt/betacatenin signaling modulators in cancer. Life Sci. 89, 545-554.
DOI
|
3 |
Saludes, J. P., Garson, M. J., Franzblau, S. G. and Aguinaldo, A. M. 2002. Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn.(Rubiaceae). Phytother. Res. 16, 683-685.
DOI
|
4 |
Samowitz, W. S., Thliveris, A., Spirio, L. N. and White, R. 1995. Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Cancer Res. 55, 3732-3734.
|
5 |
Sanmamed, M. F., Fernandez-Landazuri, S., Rodriguez, C., Zarate, R., Lozano, M. D., Zubiri, L., Perez-Gracia, J. L., Martin-Algarra, S. and Gonzalez, A. 2015. Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors. Clin. Chem. 61, 297-304.
DOI
|
6 |
Shan, B. E., Wang, M. X. and Li, R. Q. 2009. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/ -catenin signaling pathway. Cancer Invest. 27, 604-612.
DOI
|
7 |
Tetsu, O. and McCormick, F. 1999. -Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422.
DOI
|
8 |
Yun, H. J., Jung, J. H., Hyun, S. K., Kim, B. W. and Kwon, H. J. 2014. Isolation and identification of a novel anticancer compound from solanum nigrum. J. Life Sci. 24, 234-241.
DOI
|
9 |
Woodford-Richens, K., Rowan, A., Gorman, P., Halford, S., Bicknell, D., Wasan, H., Roylance, R., Bodmer, W. and Tomlinson, I. 2001. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. PNAS 98, 9719-9723.
DOI
|
10 |
Yang, J., Kim, M. O., Kwon, Y. S. and Kim, M. J. 2017. Antioxidant activity, -glucosidase inhibitory activity and chemoprotective properties of Rhododendron brachycarpum leaves extracts. Curr. Pharm. Biotechnol. 18, 849-854.
DOI
|
11 |
Bjornsti, M. A. and Houghton, P. J. 2004. The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer 4, 335.
DOI
|
12 |
Barberi-Heyob, M., Vedrine, P. O., Merlin, J. L., Millon, R., Abecassis, J., Poupon, M. F. and Guillemin, F. 2004. Wildtype p53 gene transfer into mutated p53 HT29 cells improves sensitivity to photodynamic therapy via induction of apoptosis. Int. J. Oncol. 24, 951-958.
|
13 |
Barker, N. and Clevers, H. 2006. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug Discov. 5, 997.
DOI
|
14 |
Bernkopf, D. B., Daum, G., Bruckner, M. and Behrens, J. 2018. Sulforaphane inhibits growth and blocks Wnt/-catenin signaling of colorectal cancer cells. Oncotarget 9, 33982.
DOI
|
15 |
Byun, K. S., Lee, Y. W., Jin, H. J., Lee, M. K., Lee, H. Y., Lee, K. J., Heo, M. Y., Yu, C. Y. and Lee, J. H. 2005. Genotoxicity and cytotoxicity in human cancer and normal cell lines of the extracts of Rhododendron brachycarpum D. Don leaves. Kor. J. Med. Crop Sci. 13, 199-205.
|
16 |
Chiu, S. J., Hsaio, C. H., Tseng, H. H., Su, Y. H., Shih, W. L., Lee, J. W. and Chuah, J. Q. Y. 2010. Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells. Biochem. Biophys. Res. Commun. 394, 774-779.
DOI
|
17 |
Choi, J. S., Young, H. S., Park, J. C., Choi, J. H. and Woo, W. S. 1986. Flavonoids from the leaves of Rhododendron brachycarpum. Arch. Pharm. Res. 9, 233-236.
DOI
|
18 |
Choi, Y. H., Zhou, W., Oh, J., Choe, S., Kim, D. W., Lee, S. H. and Na, M. K. 2012. Rhododendric acid A, a new ursane-type PTP1B inhibitor from the endangered plant Rhododendron brachycarpum G. Don. Bioorg. Med. Chem. Lett. 22, 6116-6119.
DOI
|
19 |
Clouse, S. D. 2002. Brassinosteroid signal transduction: clarifying the pathway from ligand perception to gene expression. Mol. Cell 10, 973-982.
DOI
|
20 |
Zhan, T., Rindtorff, N. and Boutros, M. 2017. Wnt signaling in cancer. Oncogene 36, 1461.
DOI
|
21 |
Jeong, S. K., Jeong, M. H., Jang, J. Y., Soon, J. W., Nam, B.H., Jeong, M. Z., Lim, Y. J., Jang, B. G., Youn, S. M., Lee, H. S., Hur, W. J. and Yang, K. M. 2003. Regulatory mechanism of radiation-induced cancer cell death by the change of cell cycle. Kor. Soc. Radiat. Oncol. 21, 306-314.
|
22 |
Cruz-Lozano, M., Gonzalez-Gonzalez, A., Marchal, J. A., Munoz-Muela, E., Molina, M. P., Cara, F. E., Brown, A. M., Garcia-Rivas, G., Hernandez-Brenes, C. and Lorente, J. A. 2018. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/-catenin and TGF signaling pathways. Eur. J. Nutr. 1-13.
|
23 |
Ghimeray, A. K., Lee, H. Y., Kim, Y. H., Ryu, E. K. and Chang, M. S. 2015. Evaluation of antioxidant and anti-inflammatory effect of Rhododendron brachycarpum extract used in skin care product by In Vitro and In Vivo test. Technol. Invest. 6, 105.
DOI
|
24 |
Himes, R. H., Kersey, R. N., Heller-Bettinger, I. and Samson, F. E. 1976. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36, 3798-3802.
|
25 |
Jung, K. W., Won, Y. J., Kong, H. J., Oh, C. M., Cho, H. S., Lee, D. H. and Lee, K. H. 2015. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res. Treatment 47, 127.
DOI
|
26 |
Kang, J. R. and Yoo, S. M. 2009. A study on effect on skin whitening action in Taraxacum platycarpum fractions. Asaian J. Beauty Cosmotol. 7, 199-206.
|
27 |
Kraupp, B. G., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W. and Schulte-Hermann, R. 1995. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21, 1465-1468.
DOI
|
28 |
Lu, J. J., Bao, J. L., Chen, X. P., Huang, M. and Wang, Y. T. 2012. Alkaloids isolated from natural herbs as the anticancer agents. Evid. Based Complement Altern. Med. 2012, 1-12.
|
29 |
Lanier, M., Schade, D., Willems, E., Tsuda, M., Spiering, S., Kalisiak, J., Mercola, M. and Cashman, J. R. 2012. Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response. J. Med. Chem. 55, 697-708.
DOI
|
30 |
Leow, P. C., Tian, Q., Ong, Z. Y., Yang, Z. and Ee, P. L. R. 2010. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/-catenin antagonists against human osteosarcoma cells. Invest. New Drugs 28, 766-782.
DOI
|
31 |
Nile, A. H., Mukund, S., Stanger, K., Wang, W. and Hannoush, R. N. 2017. Unsaturated fatty acyl recognition by Frizzled receptors mediates dimerization upon Wnt ligand binding. PNAS 114, 4147-4152.
DOI
|
32 |
Ohishi, K., Toume, K., Arai, M. A., Sadhu, S. K., Ahmed, F. and Ishibashi, M. 2015. Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing -catenin mRNA expression. Bioorg. Med. Chem. Lett. 25, 3937-3940.
DOI
|
33 |
Park, H. Y., Toume, K., Arai, M. A., Koyano, T., Kowithayakorn, T. and Ishibashi, M. 2014. -Sitosterol and flavonoids isolated from Bauhinia malabarica found during screening for Wnt signaling inhibitory activity. J. Nat. Med. 68, 242-245.
DOI
|
34 |
Rhim, T. J. and Choi, M. Y. 2011. The antioxidative effects of Rhododendron brachycarpum extracts. Kor. J. Plant Resour. 24, 456-460.
DOI
|
35 |
Russo, M., Siravegna, G., Blaszkowsky, L. S., Corti, G., Crisafulli, G., Ahronian, L. G., Mussolin, B., Kwak, E. L., Buscarino, M. and Lazzari, L. 2016. Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer. Cancer Res. 6, 147-153.
|